Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126409392 | 12640939 | 2 | F | 20160901 | 20160810 | 20160907 | EXP | US-GLAXOSMITHKLINE-US2016GSK115302 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160907 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126409392 | 12640939 | 1 | PS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | UNK | U | 18644 | TABLET | |||||||||
| 126409392 | 12640939 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | U | 0 | 2.25 | G | BID | ||||||
| 126409392 | 12640939 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | U | 0 | 2.25 | G | BID | ||||||
| 126409392 | 12640939 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | UNK | U | 0 | |||||||||
| 126409392 | 12640939 | 5 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.75 G, BID | U | 0 | 3.75 | G | BID | ||||||
| 126409392 | 12640939 | 6 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 20 MG, UNK | N | 0 | 20 | MG | ||||||||
| 126409392 | 12640939 | 7 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 10 MG, UNK | N | 0 | 10 | MG | ||||||||
| 126409392 | 12640939 | 8 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 126409392 | 12640939 | 9 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | UNK | U | 0 | ||||||||||
| 126409392 | 12640939 | 10 | C | XANAX | ALPRAZOLAM | 1 | 0.5 MG, UNK | U | 0 | .5 | MG | ||||||||
| 126409392 | 12640939 | 11 | C | XANAX | ALPRAZOLAM | 1 | 0.25 MG, UNK | U | 0 | .25 | MG | ||||||||
| 126409392 | 12640939 | 12 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | U | 0 | ||||||||||
| 126409392 | 12640939 | 13 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 0 | INHALATION POWDER | |||||||||
| 126409392 | 12640939 | 14 | C | BUDESONIDE. | BUDESONIDE | 1 | UNK | U | 0 | ||||||||||
| 126409392 | 12640939 | 15 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | UNK | U | 0 | ||||||||||
| 126409392 | 12640939 | 16 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | UNK | U | 0 | ||||||||||
| 126409392 | 12640939 | 17 | C | CLARITIN | LORATADINE | 1 | UNK | U | 0 | ||||||||||
| 126409392 | 12640939 | 18 | C | MODAFINIL. | MODAFINIL | 1 | UNK | U | 0 | ||||||||||
| 126409392 | 12640939 | 19 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | UNK | U | 0 | ||||||||||
| 126409392 | 12640939 | 20 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK | U | 0 | ||||||||||
| 126409392 | 12640939 | 21 | C | MEDROL | METHYLPREDNISOLONE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126409392 | 12640939 | 1 | Product used for unknown indication |
| 126409392 | 12640939 | 2 | Narcolepsy |
| 126409392 | 12640939 | 3 | Cataplexy |
| 126409392 | 12640939 | 6 | Product used for unknown indication |
| 126409392 | 12640939 | 8 | Product used for unknown indication |
| 126409392 | 12640939 | 9 | Product used for unknown indication |
| 126409392 | 12640939 | 10 | Product used for unknown indication |
| 126409392 | 12640939 | 12 | Product used for unknown indication |
| 126409392 | 12640939 | 13 | Product used for unknown indication |
| 126409392 | 12640939 | 14 | Product used for unknown indication |
| 126409392 | 12640939 | 15 | Product used for unknown indication |
| 126409392 | 12640939 | 17 | Product used for unknown indication |
| 126409392 | 12640939 | 18 | Product used for unknown indication |
| 126409392 | 12640939 | 19 | Product used for unknown indication |
| 126409392 | 12640939 | 20 | Product used for unknown indication |
| 126409392 | 12640939 | 21 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126409392 | 12640939 | HO |
| 126409392 | 12640939 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126409392 | 12640939 | Adverse drug reaction | |
| 126409392 | 12640939 | Asthma | |
| 126409392 | 12640939 | Drug interaction | |
| 126409392 | 12640939 | Lung disorder | |
| 126409392 | 12640939 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126409392 | 12640939 | 1 | 20160625 | 0 | ||
| 126409392 | 12640939 | 2 | 200505 | 2005 | 0 | |
| 126409392 | 12640939 | 3 | 201506 | 201506 | 0 | |
| 126409392 | 12640939 | 4 | 201506 | 201604 | 0 | |
| 126409392 | 12640939 | 5 | 201604 | 0 | ||
| 126409392 | 12640939 | 6 | 20151006 | 20151006 | 0 | |
| 126409392 | 12640939 | 7 | 201606 | 0 | ||
| 126409392 | 12640939 | 8 | 201607 | 0 | ||
| 126409392 | 12640939 | 9 | 20160626 | 20160706 | 0 | |
| 126409392 | 12640939 | 10 | 20160519 | 20160524 | 0 | |
| 126409392 | 12640939 | 11 | 20160524 | 201605 | 0 | |
| 126409392 | 12640939 | 12 | 20151006 | 0 | ||
| 126409392 | 12640939 | 13 | 20151006 | 0 | ||
| 126409392 | 12640939 | 14 | 20151006 | 0 | ||
| 126409392 | 12640939 | 15 | 20151006 | 201606 | 0 | |
| 126409392 | 12640939 | 16 | 20151006 | 20160524 | 0 | |
| 126409392 | 12640939 | 17 | 20151006 | 0 | ||
| 126409392 | 12640939 | 18 | 20151006 | 201604 | 0 | |
| 126409392 | 12640939 | 19 | 20151006 | 0 | ||
| 126409392 | 12640939 | 20 | 20151006 | 0 | ||
| 126409392 | 12640939 | 21 | 201607 | 0 |